Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Hereditary hemorrhagic telangiectasia, liver vascular malformations and cardiac consequences.

Ginon I, Decullier E, Finet G, Cordier JF, Marion D, Saurin JC, Dupuis-Girod S.

Eur J Intern Med. 2013 Apr;24(3):e35-9. doi: 10.1016/j.ejim.2012.12.013. Epub 2013 Jan 9.

PMID:
23312966
2.

Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: a single-center study.

Dupuis-Girod S, Chesnais AL, Ginon I, Dumortier J, Saurin JC, Finet G, Decullier E, Marion D, Plauchu H, Boillot O.

Liver Transpl. 2010 Mar;16(3):340-7. doi: 10.1002/lt.21990.

3.

Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output.

Dupuis-Girod S, Ginon I, Saurin JC, Marion D, Guillot E, Decullier E, Roux A, Carette MF, Gilbert-Dussardier B, Hatron PY, Lacombe P, Lorcerie B, Rivière S, Corre R, Giraud S, Bailly S, Paintaud G, Ternant D, Valette PJ, Plauchu H, Faure F.

JAMA. 2012 Mar 7;307(9):948-55. doi: 10.1001/jama.2012.250.

PMID:
22396517
4.

High prevalence of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.

Sopeña B, Pérez-Rodríguez MT, Portela D, Rivera A, Freire M, Martínez-Vázquez C.

Eur J Intern Med. 2013 Apr;24(3):e30-4. doi: 10.1016/j.ejim.2012.11.012. Epub 2012 Dec 13.

PMID:
23246127
5.

Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease).

Cottin V, Dupuis-Girod S, Lesca G, Cordier JF.

Respiration. 2007;74(4):361-78. Review.

PMID:
17641482
6.

Liver involvement in hereditary hemorrhagic telangiectasia (HHT).

Garcia-Tsao G.

J Hepatol. 2007 Mar;46(3):499-507. Epub 2007 Jan 2. Review.

PMID:
17239481
7.

Prevalence and nature of dyspnea in patients with hereditary hemorrhagic telangiectasia (HHT).

Rozenberg D, Leek E, Faughnan ME.

Respir Med. 2015 Jun;109(6):768-77. doi: 10.1016/j.rmed.2015.04.003. Epub 2015 Apr 15.

8.

Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry.

Lerut J, Orlando G, Adam R, Sabbà C, Pfitzmann R, Klempnauer J, Belghiti J, Pirenne J, Thevenot T, Hillert C, Brown CM, Gonze D, Karam V, Boillot O; European Liver Transplant Association.

Ann Surg. 2006 Dec;244(6):854-62; discussion 862-4.

9.

Identifying the presence of clinically significant hepatic involvement in hereditary haemorrhagic telangiectasia using a simple clinical scoring index.

Singh S, Swanson KL, Hathcock MA, Kremers WK, Pallanch JF, Krowka MJ, Kamath PS.

J Hepatol. 2014 Jul;61(1):124-31. doi: 10.1016/j.jhep.2014.02.028. Epub 2014 Mar 6.

PMID:
24607625
10.

Hepatic vascular malformations in hereditary hemorrhagic telangiectasia.

Khalid SK, Garcia-Tsao G.

Semin Liver Dis. 2008 Aug;28(3):247-58. doi: 10.1055/s-0028-1085093. Epub 2008 Sep 23. Review.

PMID:
18814078
11.
12.
13.

Doppler ultrasonographic grading of hepatic vascular malformations in hereditary hemorrhagic telangiectasia -- results of extensive screening.

Buscarini E, Danesino C, Olivieri C, Lupinacci G, De Grazia F, Reduzzi L, Blotta P, Gazzaniga P, Pagella F, Grosso M, Pongiglione G, Buscarini L, Plauchu H, Zambelli A.

Ultraschall Med. 2004 Sep;25(5):348-55.

PMID:
15368138
14.

The pulmonary vascular complications of hereditary haemorrhagic telangiectasia.

Faughnan ME, Granton JT, Young LH.

Eur Respir J. 2009 May;33(5):1186-94. doi: 10.1183/09031936.00061308. Review.

15.

Experience of the Irish National Centre for hereditary haemorrhagic telangiectasia 2003-2008.

Ni Bhuachalla CF, O' Connor TM, Murphy M, Colwell N, Brady A.

Respir Med. 2010 Aug;104(8):1218-24. doi: 10.1016/j.rmed.2010.03.003. Epub 2010 Apr 1.

16.

Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia.

Mitchell A, Adams LA, MacQuillan G, Tibballs J, vanden Driesen R, Delriviere L.

Liver Transpl. 2008 Feb;14(2):210-3. doi: 10.1002/lt.21417.

17.

Pulmonary vascular complications of hereditary haemorrhagic telangiectasia.

Circo S, Gossage JR.

Curr Opin Pulm Med. 2014 Sep;20(5):421-8. doi: 10.1097/MCP.0000000000000076. Review.

PMID:
25032812
18.

Bedside assessment of cardiac hemodynamics: the impact of noninvasive testing and examiner experience.

From AM, Lam CS, Pitta SR, Kumar PV, Balbissi KA, Booker JD, Singh IM, Sorajja P, Reeder GS, Borlaug BA.

Am J Med. 2011 Nov;124(11):1051-7. doi: 10.1016/j.amjmed.2011.05.034. Epub 2011 Sep 22.

PMID:
21944161
19.

Liver disease in hereditary hemorrhagic telangiectasia.

Larson AM.

J Clin Gastroenterol. 2003 Feb;36(2):149-58. Review.

PMID:
12544200
20.

Supplemental Content

Support Center